| NCT ID | NCT06656299 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Sehit Prof. Dr. Ilhan Varank Sancaktepe Training and Research Hospital |
| Condition | Cholecystitis |
| Study Type | INTERVENTIONAL |
| Enrollment | 60 participants |
| Start Date | 2024-10-30 |
| Primary Completion | 2025-11-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 60 participants in total. It began in 2024-10-30 with a primary completion date of 2025-11-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Laparoscopic cholecystectomy, while less painful compared to conventional methods, is still a surgery that can cause significant pain for patients. Preventing postoperative pain is crucial for reducing respiratory complications, shortening hospital stays, and increasing patient satisfaction. Interfascial plane blocks have been widely used for postoperative analgesia in recent years worldwide. The External Oblique Intercostal Plane Block is one of the interfascial plane blocks used in abdominal surgeries. In our study, we aimed to compare the postoperative pain scores of patients who underwent laparoscopic cholecystectomy under general anesthesia, specifically between those who received the external oblique intercostal plane block and those who had trocar entry site infiltration.
Eligibility Criteria
Inclusion Criteria: * Patients aged 18 to 65 who will be scheduled for an elective laparoscopic cholecystectomy under general anesthesia * ASA (American Society of Anesthesiologists) I-II-III Exclusion Criteria: * presence of coagulation disorder * infection at the injection site of the block * known allergy to local anesthetics * advanced hepatic, heart or renal failure * history of abdominal surgery or trauma * conversion of laparoscopic to open surgery * consumption of any pain killers within the 24 h before the operation * chronic opioid consumption * pregnancy * alcohol or drug abuse * body mass index (BMI) ≥ 35 kg m-2 * Impairment of the patient's cognitive functions (such as Alzheimer's disease, dementia, etc.). * Cholecystectomy cases performed under emergency conditions.
Frequently Asked Questions
Who can join the NCT06656299 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Cholecystitis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06656299 currently recruiting?
Yes, NCT06656299 is actively recruiting participants. Visit ClinicalTrials.gov or contact Sehit Prof. Dr. Ilhan Varank Sancaktepe Training and Research Hospital to inquire about joining.
Where is the NCT06656299 trial being conducted?
This trial is being conducted at Istanbul, Turkey (Türkiye).
Who is sponsoring the NCT06656299 clinical trial?
NCT06656299 is sponsored by Sehit Prof. Dr. Ilhan Varank Sancaktepe Training and Research Hospital. The trial plans to enroll 60 participants.